Chopping close to home, Novartis outlines plans to ax or move about 2,600 more jobs in another wave of global restructuring
Novartis is continuing its piecemeal plan to restructure the global pharma company, once again bringing out the ax as it reshapes its manufacturing and services operations in Europe this time.
Close to 2,200 jobs are being eliminated in its home country of Switzerland in the next four years. That includes roughly 1,500 staff at production facilities it runs in Basel, Stein, Locarno and Schweizerhalle. Another 700 service jobs in Basel — which is home — are being redistributed to one of five global centers in Dublin, Hyderabad, Kuala Lumpur, Mexico City and Prague.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.